The price-to-earnings ratio for CME Group Inc (NASDAQ: CME) is 23.37x, which is above its average ratio. Moreover, the 36-month beta value for CME is 0.49. Analysts have varying opinions on the stock, with 5 analysts rating it as a “buy,” 4 as “overweight,” 5 as “hold,” and 0 as “sell.”
The public float for CME is 358.74M and currently, short sellers hold a 1.23% of that float. On April 17, 2024, CME’s average trading volume was 1.69M shares.
CME) stock’s latest price update
CME Group Inc (NASDAQ: CME)’s stock price has gone rise by 0.29 in comparison to its previous close of 206.48, however, the company has experienced a -2.33% decrease in its stock price over the last five trading days. Zacks Investment Research reported 2024-04-17 that CME (CME) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CME’s Market Performance
CME Group Inc (CME) has experienced a -2.33% fall in stock performance for the past week, with a -5.40% drop in the past month, and a 2.02% rise in the past quarter. The volatility ratio for the week is 1.86%, and the volatility levels for the past 30 days are at 1.60% for CME. The simple moving average for the past 20 days is -2.58% for CME’s stock, with a 1.33% simple moving average for the past 200 days.
Analysts’ Opinion of CME
Many brokerage firms have already submitted their reports for CME stocks, with Barclays repeating the rating for CME by listing it as a “Equal Weight.” The predicted price for CME in the upcoming period, according to Barclays is $222 based on the research report published on January 08, 2024 of the current year 2024.
Goldman, on the other hand, stated in their research note that they expect to see CME reach a price target of $195. The rating they have provided for CME stocks is “Sell” according to the report published on January 03rd, 2024.
BofA Securities gave a rating of “Neutral” to CME, setting the target price at $204 in the report published on September 06th of the previous year.
CME Trading at -3.10% from the 50-Day Moving Average
After a stumble in the market that brought CME to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -6.99% of loss for the given period.
Volatility was left at 1.60%, however, over the last 30 days, the volatility rate increased by 1.86%, as shares sank -4.31% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +1.09% upper at present.
During the last 5 trading sessions, CME fell by -2.34%, which changed the moving average for the period of 200-days by +11.74% in comparison to the 20-day moving average, which settled at $212.09. In addition, CME Group Inc saw -1.68% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CME starting from SHEPARD WILLIAM R, who purchase 282 shares at the price of $214.71 back on Mar 26 ’24. After this action, SHEPARD WILLIAM R now owns 253,343 shares of CME Group Inc, valued at $60,561 using the latest closing price.
SHEPARD WILLIAM R, the Director of CME Group Inc, purchase 12 shares at $214.71 during a trade that took place back on Mar 26 ’24, which means that SHEPARD WILLIAM R is holding 2,334 shares at $2,670 based on the most recent closing price.
Stock Fundamentals for CME
Current profitability levels for the company are sitting at:
- 0.62 for the present operating margin
- 0.84 for the gross margin
The net margin for CME Group Inc stands at 0.58. The total capital return value is set at 0.09. Equity return is now at value 12.05, with 2.12 for asset returns.
Based on CME Group Inc (CME), the company’s capital structure generated 0.12 points at debt to capital in total, while cash flow to debt ratio is standing at 0.99. The debt to equity ratio resting at 0.13. The interest coverage ratio of the stock is 21.55.
Currently, EBITDA for the company is 3.79 billion with net debt to EBITDA at 0.37. When we switch over and look at the enterprise to sales, we see a ratio of 13.52. The receivables turnover for the company is 4.46for trailing twelve months and the total asset turnover is 0.04.
Conclusion
To wrap up, the performance of CME Group Inc (CME) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
